Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01998035
Title Romidepsin Plus Oral 5-Azacitidine in Relapsed/Refractory Lymphoid Malignancies
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Owen A, O'Connor, M.D., Ph.D.
Indications

lymphoma

Therapies

Azacitidine + Romidepsin

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.